Smith Graham & Co Investment Advisors’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $4.58M | Sell |
9,997
-1,018
| -9% | -$502K | 0.53% | 89 |
|
|
2023
Q3 | $5.36M | Sell |
11,015
-105
| -0.9% | -$49.3K | 0.67% | 63 |
|
|
2023
Q2 | $4.97M | Sell |
11,120
-105
| -0.9% | -$52.9K | 0.6% | 77 |
|
|
2023
Q1 | $5.45M | Sell |
11,225
-276
| -2% | -$136K | 0.66% | 66 |
|
|
2022
Q4 | $5.89M | Sell |
11,501
-269
| -2% | -$141K | 0.72% | 60 |
|
|
2022
Q3 | $5.71M | Sell |
11,770
-683
| -5% | -$332K | 0.76% | 51 |
|
|
2022
Q2 | $5.83M | Sell |
12,453
-301
| -2% | -$134K | 0.72% | 55 |
|
|
2022
Q1 | $5.55M | Buy |
12,754
+429
| +3% | +$179K | 0.58% | 83 |
|
|
2021
Q4 | $5.72M | Sell |
12,325
-187
| -1% | -$82.8K | 0.57% | 78 |
|
|
2021
Q3 | $4.87M | Sell |
12,512
-1,375
| -10% | -$584K | 0.49% | 91 |
|
|
2021
Q2 | $6.15M | Sell |
13,887
-2,081
| -13% | -$909K | 0.54% | 80 |
|
|
2021
Q1 | $6.7M | Sell |
15,968
-2,029
| -11% | -$810K | 0.54% | 80 |
|
|
2020
Q4 | $7.38M | Sell |
17,997
-1,737
| -9% | -$722K | 0.68% | 62 |
|
|
2020
Q3 | $8.17M | Sell |
19,734
-870
| -4% | -$350K | 0.93% | 31 |
|
|
2020
Q2 | $7.99M | Sell |
20,604
-1,912
| -8% | -$715K | 0.97% | 31 |
|
|
2020
Q1 | $7.07M | Buy |
22,516
+160
| +0.7% | +$54K | 1.1% | 20 |
|
|
2019
Q4 | $8.19M | Sell |
22,356
-580
| -3% | -$184K | 0.8% | 54 |
|
|
2019
Q3 | $5.86M | Buy |
22,936
+50
| +0.2% | +$14K | 0.62% | 83 |
|
|
2019
Q2 | $6.07M | Sell |
22,886
-960
| -4% | -$243K | 0.65% | 75 |
|
|
2019
Q1 | $6.34M | Buy |
23,846
+230
| +1% | +$66.3K | 0.7% | 65 |
|
|
2018
Q4 | $6.77M | Sell |
23,616
-110
| -0.5% | -$34.9K | 0.83% | 44 |
|
|
2018
Q3 | $8.03M | Sell |
23,726
-910
| -4% | -$296K | 0.76% | 55 |
|
|
2018
Q2 | $7.33M | Sell |
24,636
-520
| -2% | -$152K | 0.69% | 69 |
|
|
2018
Q1 | $6.76M | Sell |
25,156
-310
| -1% | -$83.9K | 0.65% | 76 |
|
|
2017
Q4 | $6.32M | Buy |
25,466
+4,510
| +22% | +$1.11M | 0.59% | 89 |
|
|
2017
Q3 | $5.11M | Sell |
20,956
-170
| -0.8% | -$41.7K | 0.54% | 85 |
|
|
2017
Q2 | $5.08M | Sell |
21,126
-210
| -1% | -$47.5K | 0.55% | 85 |
|
|
2017
Q1 | $4.4M | Sell |
21,336
-130
| -0.6% | -$26.9K | 0.47% | 104 |
|
|
2016
Q4 | $4.38M | Sell |
21,466
-1,700
| -7% | -$324K | 0.47% | 101 |
|
|
2016
Q3 | $4.1M | Sell |
23,166
-340
| -1% | -$59K | 0.52% | 96 |
|
|
2016
Q2 | $4.23M | Sell |
23,506
-150
| -0.6% | -$26.6K | 0.58% | 89 |
|
|
2016
Q1 | $4.33M | Buy |
23,656
+2,430
| +11% | +$422K | 0.57% | 88 |
|
|
2015
Q4 | $3.79M | Buy |
21,226
+700
| +3% | +$123K | 0.54% | 90 |
|
|
2015
Q3 | $3.67M | Buy |
20,526
+440
| +2% | +$81.3K | 0.54% | 86 |
|
|
2015
Q2 | $3.84M | Sell |
20,086
-3,260
| -14% | -$605K | 0.52% | 80 |
|
|
2015
Q1 | $4.16M | Sell |
23,346
-160
| -0.7% | -$25.3K | 0.56% | 77 |
|
|
2014
Q4 | $3.38M | Buy |
23,506
+390
| +2% | +$53.3K | 0.48% | 94 |
|
|
2014
Q3 | $3.01M | Buy |
23,116
+1,370
| +6% | +$174K | 0.44% | 92 |
|
|
2014
Q2 | $2.78M | Sell |
21,746
-230
| -1% | -$27.2K | 0.39% | 98 |
|
|
2014
Q1 | $2.48M | Sell |
21,976
-300
| -1% | -$31.3K | 0.36% | 109 |
|
|
2013
Q4 | $2.3M | Sell |
22,276
-8,070
| -27% | -$791K | 0.33% | 113 |
|
|
2013
Q3 | $2.83M | Buy |
+30,346
| New | +$2.78M | 0.41% | 111 |
|
Other funds holding HUM
Smith Graham & Co Investment Advisors's HUM Position: Q4 2023 in Review
Smith Graham & Co Investment Advisors reduced its Humana (HUM) stake by 9.2% in Q4 2023, selling an estimated $502K and leaving 9,997 shares worth $4.58M. The position accounts for 0.53% of the portfolio, ranked #89.
Smith Graham & Co Investment Advisors first reported a position in HUM in Q3 2013 and has held it in 42 quarters since. The position peaked at $8.19M in Q4 2019. 1,152 funds tracked by Wall St. Rank hold HUM as of Q4 2023.
- Smith Graham & Co Investment Advisors held 9,997 shares of Humana worth $4.58M as of Q4 2023.
- Smith Graham & Co Investment Advisors sold 1,018 Humana shares in Q4 2023, an estimated $502K.
- Humana made up 0.53% of Smith Graham & Co Investment Advisors's portfolio in Q4 2023, its #89 holding.
- Smith Graham & Co Investment Advisors first reported a position in Humana in Q3 2013 and has held it in 42 quarters since.
- Smith Graham & Co Investment Advisors's Humana position peaked at $8.19M in Q4 2019.
- 1,152 funds tracked by Wall St. Rank held Humana as of Q4 2023.
Based on Smith Graham & Co Investment Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.